Fisetin can be used in the future, as a target for the treatment of metastasis of human osteosarcoma cells. - GreenMedInfo Summary
Fistein Suppresses Human Osteosarcoma U-2 OS Cell Migration and InvasionAffecting FAK, uPA and NF-ĸB Signaling Pathway.
In Vivo. 2019 May-Jun;33(3):801-810. PMID: 31028200
Jr-Kai Chen
BACKGROUND/AIM: Evidence has indicated that fisetin induces cytotoxic effects in human cancer cell lines, including the inhibition of cell migration and invasion, however, the exact molecular mechanism of action of fisetin in human osteosarcoma cells remains unclear.
MATERIALS AND METHODS: The anti-metastatic mechanisms of fisetin in human osteosarcoma U-2 OS cells were investigated in vitro.
RESULTS: Fisetin reduced the viability of cells at different concentrations (2.5, 5 and 10μM) as measured by flow cytometric assay. Fisetin suppressed cell mobility, migration and invasion of U-2 OS cells, as shown by wound healing assay and transwell filter chambers, respectively. The gelatin zymography assay showed that fisetin inhibited MMP-2 activity in U-2 OS cells. Results from western blotting indicated that fisetin reduced the levels of pEGFR, SOS-1, GRB2, Ras, PKC, p-ERK1/2, p-JNK, p-p-38, VEGF, FAK, RhoA, PI3K, p-AKT, NF-ĸB, uPA, MMP-7, MMP-9, and MMP-13, but increased GSK3β and E-cadherin in U-2 OS cells after 48 h of treatment.
CONCLUSION: Fisetin can be used in the future, as a target for the treatment of metastasis of human osteosarcoma cells.
